Selvakumar Kanthiah
Research Subjects
Selvakumar Kanthiah has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Joysa Ruby Joseph
Department of Pharmaceutics, Acharya and BM Reddy College of Pharmacy, Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka, India
2 shared publications - Ajay Pankajbhai Lunagariya1 shared publication
- Chandrika P1 shared publication
Hiriyanna Sgb
Department of Pharmaceutical Quality Assurance Acharya & BM Reddy College of Pharmacy Bengaluru Karnataka India
1 shared publication- Kavitha Choudhary1 shared publication
- Shreyas S Kashyap1 shared publication
Latest Publications
- Open Access
- 7 April 2025
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 10 (2) , 79-84
Extraction and Formulation of Lip Tint from Natural Dye Extracted from Celosia Cristata Linn Flower
The escalating utilisation of synthetic dyes across diverse industries, including textiles, cosmeceuticals, food, and pharmaceuticals, is projected to witness a notable 6.5 % surge by 2027, notwithstanding the well-documented drawbacks associated with their usage. Synthetic dyes have been linked to adverse effects such as skin irritation, necrosis, genotoxicity, and hyperactivity in children. Acknowledging the imperative need to transition towards safer alternatives, this study investigates the extraction and formulation of a lip tint employing a dye derived from Celosia cristata Linn as a natural substitute for synthetic dyes. The aqueous extraction of Celosia cristata Linn flower unveiled the presence of various phytochemical constituents, including flavonoids, tannins, phenols, steroids, terpenoids, quinones, cellulose, starch, and saponins. Particularly noteworthy is the betalain constituent in the flower extract, which imparts the dye with nutraceutical, antioxidant, and anti-inflammatory properties. The formulated lip tint underwent a comprehensive evaluation encompassing dye stability, spreadability, melting point, skin irritation, surface anomalies, homogeneity, perfume stability, pH, short-term stability, and colorant yield. The study concludes that the lip tint formulated from Celosia cristata Linn dye represents a viable and safe alternative for various cosmeceutical applications, providing a natural solution to the adverse effects associated with synthetic dyes.
- 7 April 2025
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 10 (2) , 79-84
Open AccessExtraction and Formulation of Lip Tint from Natural Dye Extracted from Celosia Cristata Linn Flower
The escalating utilisation of synthetic dyes across diverse industries, including textiles, cosmeceuticals, food, and pharmaceuticals, is projected to witness a notable 6.5 % surge by 2027, notwithstanding the well-documented drawbacks associated with their usage. Synthetic dyes have been linked to adverse effects such as skin irritation, necrosis, genotoxicity, and hyperactivity in children. Acknowledging the imperative need to transition towards safer alternatives, this study investigates the extraction and formulation of a lip tint employing a dye derived from Celosia cristata Linn as a natural substitute for synthetic dyes. The aqueous extraction of Celosia cristata Linn flower unveiled the presence of various phytochemical constituents, including flavonoids, tannins, phenols, steroids, terpenoids, quinones, cellulose, starch, and saponins. Particularly noteworthy is the betalain constituent in the flower extract, which imparts the dye with nutraceutical, antioxidant, and anti-inflammatory properties. The formulated lip tint underwent a comprehensive evaluation encompassing dye stability, spreadability, melting point, skin irritation, surface anomalies, homogeneity, perfume stability, pH, short-term stability, and colorant yield. The study concludes that the lip tint formulated from Celosia cristata Linn dye represents a viable and safe alternative for various cosmeceutical applications, providing a natural solution to the adverse effects associated with synthetic dyes.
- 22 February 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (4) , e70031
Navigating the AQbD Landscape: Enhancing Quality Management in Liquid Chromatography Method Development
The implementation of ‘Analytical Quality by Design’ (AQbD) is currently recognised as a methodical and scientific approach to liquid chromatographic (LC) method development. It begins with defining the Analytical Target Profile (ATP), identifying Critical Method Parameters (CMPs) and Critical Quality Attributes (CQAs) or responses. This process also includes risk assessment study by Design of Experiment (DoE) and to optimise LC effectively. The next step is to create an analytical design space and implement a control strategy that will allow for continuous method improvement over the life of the method. Understanding the AQbD principles, methodologies, techniques and applications towards the high‐performance liquid chromatography (HPLC) method lifecycle is considered as essential in today's pharmaceutical landscape. As industry demands for quality assurance and regulatory compliance, this review paper briefly discusses the AQbD principles and methodology in HPLC method lifecycle. Also, the paper covers AQbD components such as identification of ATP, CQA, MODR (method operable design region), control strategies and continuous method monitoring. In addition, it also covers regulatory perspectives on AQbD, obstacles and potential outcomes in the development of pharmaceutical analytical methods. These aspects provide valuable insights into the application of AQbD in the field of LC.
- 22 February 2025
- Published by Wiley in Biomedical Chromatography
- Vol. 39 (4) , e70031
Navigating the AQbD Landscape: Enhancing Quality Management in Liquid Chromatography Method Development
The implementation of ‘Analytical Quality by Design’ (AQbD) is currently recognised as a methodical and scientific approach to liquid chromatographic (LC) method development. It begins with defining the Analytical Target Profile (ATP), identifying Critical Method Parameters (CMPs) and Critical Quality Attributes (CQAs) or responses. This process also includes risk assessment study by Design of Experiment (DoE) and to optimise LC effectively. The next step is to create an analytical design space and implement a control strategy that will allow for continuous method improvement over the life of the method. Understanding the AQbD principles, methodologies, techniques and applications towards the high‐performance liquid chromatography (HPLC) method lifecycle is considered as essential in today's pharmaceutical landscape. As industry demands for quality assurance and regulatory compliance, this review paper briefly discusses the AQbD principles and methodology in HPLC method lifecycle. Also, the paper covers AQbD components such as identification of ATP, CQA, MODR (method operable design region), control strategies and continuous method monitoring. In addition, it also covers regulatory perspectives on AQbD, obstacles and potential outcomes in the development of pharmaceutical analytical methods. These aspects provide valuable insights into the application of AQbD in the field of LC.